PFBT
CGEM icon

Parkside Financial Bank & Trust’s Cullinan Oncology CGEM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60
Closed -$356 – 2709
2025
Q3 		$356 Hold
60
– – ﹤0.01% 2622
2025
Q2 		$452 Buy
+60
New +$482 ﹤0.01% 2600

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Parkside Financial Bank & Trust's CGEM Position: Q4 2025 in Review

Parkside Financial Bank & Trust sold out of Cullinan Oncology (CGEM) in Q4 2025, closing a stake of 60 shares — an estimated $356 sold.

Parkside Financial Bank & Trust first reported a position in CGEM in Q2 2025 and held it in 2 quarters. The position peaked at $452 in Q2 2025. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.

  • Parkside Financial Bank & Trust reported no remaining Cullinan Oncology position as of Q4 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 60 Cullinan Oncology shares in Q4 2025, an estimated $356.
  • Parkside Financial Bank & Trust first reported a position in Cullinan Oncology in Q2 2025 and held it in 2 quarters.
  • Parkside Financial Bank & Trust's Cullinan Oncology position peaked at $452 in Q2 2025.
  • 153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2025, filed 13 Feb 2026.